MedTrace Logo

Compression Nail for Tibiocalcaneal Arthrodesis

NCT03780452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2025-05-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the clinical efficacy of a novel dynamic compression intramedullary nail for tibiotalocalcaneal (TTC) arthrodesis

Conditions

  • Subtalar Arthritis
  • Ankle Arthritis

Interventions

DEVICE

novel dynamic compression intramedullary nail

Tibiotalocalcaneal (TTC) arthrodesis with a novel dynamic compression intramedullary nail. The assignment of the device is at the discretion of the standard of care provider, not the study investigator.

Sponsors & Collaborators

  • MedShape, Inc

    collaborator INDUSTRY

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • ashish shah, md · University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2024-07-10
Completion
2024-07-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03780452 on ClinicalTrials.gov